Evidence map›Paper›PMID 38860029›Full record

ArticleJournal of asthma and allergy2024

Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry.

Nijra L Lugogo, Enrico Heffler, Vicente Plaza, Ole Hilberg, Changming Xia, Scott Nash, Nami Pandit, Juby A Jacob-Nara, Harry J Sacks, Paul J Rowe and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of asthma and allergy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nijra L LugogoUniversity of Michigan Medical School, Ann Arbor, MI, USA.ORCID 0000-0002-0235-7105
Enrico HefflerIRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.ORCID 0000-0002-0492-5663
Vicente PlazaHospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID 0000-0003-2567-5496
Ole HilbergLillebaelt Hospital, Vejle, Denmark.ORCID 0000-0002-3075-3463
Changming XiaRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.ORCID 0000-0002-5703-5074
Scott NashRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Nami PanditSanofi, Bridgewater, NJ, USA.ORCID 0000-0002-1072-2897
Juby A Jacob-NaraSanofi, Bridgewater, NJ, USA.ORCID 0000-0002-5372-8762
Harry J SacksRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.ORCID 0000-0002-8191-2866
Paul J RoweSanofi, Bridgewater, NJ, USA.
Yamo DenizRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.ORCID 0000-0003-1655-5628
Megan HardinSanofi, Cambridge, MA, USA.ORCID 0000-0001-7622-9598
Xavier SolerRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38860029
PMCPMC11164082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.